COVID-19 restricts Indian pharma export growth to 7.6 per cent in FY’20 Usha Sharma May 8, 2020 India exported pharma products to 202 destinations in FY’20
2019-nCoV must reform India Pharma Inc Viveka Roychowdhury Feb 12, 2020 Urgent regulatory reform is needed to spur more proactive policies for proposed bulk drug and API parks which will make the…
Government working on recommendations to reduce bulk drug imports Arunava Biswas Apr 19, 2016 The government had set up a committee headed by Secretary, Health Research, V M Katoch to suggest ways to reduce dependency on…
